Telmisartan Impurity 11 | CAS 1016696-74-4 - Request Quote
Telmisartan Impurity 11
| SZ CAT No: | SZ-T006039 |
| CAS No | 1016696-74-4 |
| Mol.F. | C12H15NO3 |
| Mol.Wt. | 221.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Telmisartan Impurity 11 is chemically 4-Butyramido-3-methylbenzoic acid. Telmisartan Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Telmisartan Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Telmisartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1016696-74-4
Purchase 1016696-74-4
Order 1016696-74-4
Enquire 1016696-74-4
price of 1016696-74-4
1016696-74-4 Supplier
1016696-74-4 Manufacturer
1016696-74-4 Exporter
buy high quality Telmisartan Impurity 11
Purchase Telmisartan Impurity 11
Telmisartan Impurity 11 suppliers
Telmisartan Impurity 11 manufacturers
Telmisartan Impurity 11 price
Order Telmisartan Impurity 11
Enquire Telmisartan Impurity 11
Telmisartan Impurity 11 cost
Telmisartan Impurity 11 Supplier
Telmisartan Impurity 11 Distributor
Telmisartan Impurity 11 for Method Validation
Telmisartan Reference Standard
Telmisartan Impurity 11 for ANDA Filing
Telmisartan Impurity 11 for Forced Degradation Studies
Telmisartan Impurity 11 Identification Standards
Telmisartan Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.